Hanmi Pharmaceutical Announces Multinational Phase IIb Clinical Studies on LAPS-Exendin4, New Biological Drug for Diabetes

Marketwired
Hanmi Pharmaceutical Announces Multinational Phase IIb Clinical Studies on LAPS-Exendin4, New Biological Drug for Diabetes
Hanmi Pharmaceutical Co., Ltd. Logo
View Comments (0)